Woman and Man
- | Country :
- Ukraine
- Italy
- United States
- | organs : -
- | Specialty : -
Extract
The primary efficacy objective of this study is to evaluate the difference in coefficient of fat absorption (CFA) of participants treated with high dose EUR-1008 (APT-1008) versus low dose of EUR-1008 (APT-1008) in the treatment of signs and symptoms of malabsorption in participants with EPI associated with CP. This study is sponsored by Aptalis Pharma (formerly Eurand).
Inclusion criteria
- Chronic pancreatitis ,Exocrine Pancreatic Insufficiency